Drugs / Troplasminogen alfa
Troplasminogen alfa
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00144014 | Aug 2005 → Nov 2008 | ischemic stroke | Vernalis (R&D) Ltd | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Troplasminogen alfa | “Proposed INN: Troplasminogen alfa” NCT00144014 ↗ |
| Known as | BB-10153 | “Code Names: V10153, BB-10153” NCT00144014 ↗ |
| Known as | Troplasminogene alfa | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108353 ↗ |
| Known as | Troplasminogeno alfa | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108353 ↗ |
| Known as | V10153 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00144014 ↗ |
| Route | Intravenous | “single intravenous dose” NCT00144014 ↗ |